Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 20, 2025
Reporting period
Not applicable
Filed with the SEC
Nov 21, 2025
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000064803-25-000061
Filed / recorded
Nov 21, 2025, 10:41 PM UTC
Added to OQRO
Oct 2, 2026, 3:52 AM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
CVS HEALTH Corp
Issuer CIK
64803
Ticker
CVS
Reporting person
Anne A. Finucane
Relationship
Director
Security
Deferred Stock Units
Table
Derivative (Table II)
Transaction date
Nov 20, 2025
Transaction code
A
Shares / units
1,775.3814
Price per share
$76.04
Acquired / disposed
Acquired (A)
Shares owned after
16,530.0615
Ownership form
Direct
Amendment
No
Footnotes from the filing
Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.
Around the same time
Congress tradeSits on House Ways and Means, Health
Congress tradeSits on House Ways and Means, Health